Gitte A. Dam

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids".

Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids".

Journal: Journal of neuroendocrinology

Published: June 09, 2026

Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults.

Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults.

Journal: European journal of endocrinology

Published: February 17, 2026

Clinical Presentation and Outcomes of Sporadic Neuroendocrine Neoplasms in Young Adults.

Clinical Presentation and Outcomes of Sporadic Neuroendocrine Neoplasms in Young Adults.

Journal: European journal of endocrinology

Published: February 17, 2026

Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

Journal: The Cochrane database of systematic reviews

Published: January 16, 2026

Follow-up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi-ENETS Center of Excellence Study.

Follow-up is not justified in patients with typical lung carcinoids without lymph node involvement treated with curative intent: A Danish Multi-ENETS Center of Excellence Study.

Journal: Journal of neuroendocrinology

Published: June 24, 2025

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy.

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy.

Journal: Frontiers in endocrinology

Published: September 12, 2024

Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study.

Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study.

Journal: Cancers

Published: February 26, 2024

Case of primary low-grade neuroendocrine carcinoma of the skin.

Case of primary low-grade neuroendocrine carcinoma of the skin.

Journal: BMJ case reports

Published: December 18, 2023

Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study.

Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 08, 2023

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 17, 2023

The role of N-terminal pro-brain natriuretic peptide, chromogranin A, and 5-hydroxyindoleacetic acid in screening for carcinoid heart disease.

The role of N-terminal pro-brain natriuretic peptide, chromogranin A, and 5-hydroxyindoleacetic acid in screening for carcinoid heart disease.

Journal: Journal of neuroendocrinology

Published: January 11, 2023

Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours.

Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: September 21, 2022

Showing 1-12 of 55

Last Updated: 09/26/2026